AfPA Summit on Biologics and Biosimilars
April 12, 2016
The Alliance for Patient Access, the Institute for Patient Access and the Biologics Prescribers Collaborative welcomed health care providers, advocates, patients and other stakeholders for the National Policy & Advocacy Summit on Biologics and Biosimilars in Washington, DC on April 12, 2016.
The summit featured remarks from FDA’s Steven Kozlowski, MD, who described the agency’s efforts to determine follow-on drugs’ biosimilarity to their biologic predecessors, and Representative Brad Wenstrup (R-Ohio) of the House Doctors Caucus, who emphasized the importance of the physician-patient relationship and acknowledged the value of innovative medicines such as biologics.
Dennis Cryer, MD, of the Biologics Prescribers Collaborative echoed the need for patient-centered policies, as did Larry LaMotte from Patients for Biologics Safety and Access. Dr. Cryer introduced The Biosimilar Promise, a new handbook from the Biologics Prescribers Collaborative.